Skip to content

CARTO 3 Human Patch Study

CARTO 3 ACL Patches Effectiveness Over Prolonged Clinical Case

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00767390
Acronym
Human Patch
Enrollment
0
Registered
2008-10-07
Start date
2008-10-31
Completion date
Unknown
Last updated
2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

ACL Patch Placement

Brief summary

The Purpose of this clinical investigation is to observe the changes in relative conductivity between the six ACL patches over time. In addition, the clinical investigation will evaluate the impact of prolonged placement of the ACL patches on subjects' skin on the chest and back. During the study the adhesiveness properties of the patches will be evaluated.

Interventions

DEVICEACL Patch

Observe and characterize the changes in relative conductivity between the six ACL patches over period of six hours. Investigation only involves passive data collection on pressure impact and adhesiveness properties of ACL patches.

Sponsors

Biosense Webster, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Signed Subject Informed Consent Form * Healthy subject * Age Range: 20 - 50 years * BMI - half o the subjects 18-25 and half \>25 * Chest cage normal anatomy and dimensions * No history of skin contact patch allergy, of any kind

Exclusion criteria

* Chest cage bony deformity * Known skin allergies to patches, or dermatological conditions requiring therapy * Presence of any active skin lesion on chest or back * Any condition that preclude subject from lying down for six hours with minimal movement * Pregnancy * Subjects with devices, such as pace makers, IC, loop recorder

Design outcomes

Primary

MeasureTime frame
Absence of any clinically significant trauma to skin of the subjects at the ACL patches placement sites.6 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026